Wednesday, August 15, 2012

CCO-Annual Update: New HCV Agents

Clinical Care Options - Hepatitis

*Free registration required

Annual Update

HIV and Hepatitis C Annual Update 2012

Expert faculty members review scientific and clinical advances of the past year.

Now Available!

CME/CE/ACPE-Certified Modules:
/upload/global/headshots/fried_michael.jpg
Using Boceprevir and Telaprevir in Clinical PracticeMichael W. Fried, MD, reviews key factors that patients and treatment providers must consider before beginning boceprevir- or telaprevir-based triple therapy as well as important on-treatment management strategies.
/upload/global/headshots/nelson_david.jpg
New HCV AgentsDavid R. Nelson, MD, reviews the latest data on emerging agents under investigation for the treatment of chronic HCV infection.
/upload/global/headshots/chaisson_richard.jpg
Management of Tuberculosis in HIV-Infected PatientsRichard E. Chaisson, MD, reviews the latest data on key issues related to the prevention, diagnosis, and treatment of tuberculosis in patients with HIV infection.
/upload/global/headshots/rockstroh_jurgen.jpg
Optimal Use of Direct-Acting Antiviral Agents in the Treatment of HIV/HCV-Coinfected PatientsJ├╝rgen K. Rockstroh, MD, reviews current guidelines and recent clinical data and provides expert perspective regarding the concomitant use of HIV and HCV therapies in coinfected patients.

Coming Soon!

CME/CE/ACPE-Certified Modules:
/upload/global/headshots/eron_joseph.jpg 2012 Update on Antiretroviral Therapy
/upload/global/headshots/powderly_william.jpg Long-term Complications of HIV and Antiretroviral Therapy

Downloadable PowerPoint Slideset:
HIV and Hepatitis C Annual Update 2012

No comments:

Post a Comment